FatiAbGen

Seoul, Korea

Collaborations & Partnerships- R&DCollaborations & Partnerships-LicensingCollaborations & Partnerships-ManufactureCollaborations & Partnerships-ServicesProprietary Research & Manufacture Basic Listing
C-Score
29%
Developing Profile
Company Details
Address Seoul
Country Korea
Sectors Collaborations & Partnerships- R&D, Collaborations & Partnerships-Licensing, Collaborations & Partnerships-Manufacture, Collaborations & Partnerships-Services, Proprietary Research & Manufacture
Website Visit Website
Company Activities

FatiAbGen is a leading antibody engineering company leveraging collaborations across the global biotech ecosystem to deverlop best-in-class therapeuties for high unmet need oncology and immunology conditions. FatiAbGen has a strong global view with passion. FatiAbGen is the first Korean company to be a member of Shonan iPark, the largest biotech cluster in Japan. FatiAbGen became a member of the JLABS family in 2023, strongly aligned with J&J’s innovative portfolio. In 2024, FatiAbGen established a new subsidiary in Basel Switzerland to accelerate business development for future out-licensing.

Sectors
Collaborations & Partnerships- R&D
Collaborations & Partnerships-Licensing
Collaborations & Partnerships-Manufacture
Collaborations & Partnerships-Services
Proprietary Research & Manufacture
Category/Key Word(s)
Biologics
Antibodies-Bi-specific-Multi-specific
Antibodies-monoclonals
Antibody Drug Conjugates
Platform Technology-Drug Discovery
Platform Technology-Drug Development
immuno-oncology
Immunology
Autoimmune Products
Clinical Development-Pipeline
Anti-Infection Products
Company Contacts

No key contacts have been added to this profile yet.

Company Reviews

No reviews have been added to this profile yet.

Claim This Profile

This is the company profile page for FatiAbGen on the Pharmaceutical Services Directory. Companies listed on the directory can update their business information free of charge. If this is your company and you'd like to claim this profile, please Contact Us.

Company Pages
Overview Partnerships News Financials Media Locations Blogs